| |
| |
|
| Insider
Information: |
Gline Matthew |
| Relationship: |
|
| City: |
London |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,153,706 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,956,118 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,153,706 |
|
|
| Total
Value |
$12,956,118 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Roivant Sciences Ltd. |
ROIV |
|
2024-04-20 |
1,153,706 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-03-07 |
4 |
AS |
$5.52 |
$509,628 |
D/D |
(92,324) |
1,589,289 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-03-18 |
4 |
AS |
$5.13 |
$420,691 |
D/D |
(82,006) |
1,507,283 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-03-25 |
4 |
AS |
$5.06 |
$179,053 |
D/D |
(35,386) |
1,471,897 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-03-30 |
4 |
AS |
$4.84 |
$163,040 |
D/D |
(33,686) |
1,438,211 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-04-25 |
4 |
AS |
$3.84 |
$32,675 |
D/D |
(8,509) |
1,404,448 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-06-23 |
4 |
AS |
$4.34 |
$86,171 |
D/D |
(19,855) |
1,244,802 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-07-25 |
4 |
AS |
$4.33 |
$88,570 |
D/D |
(20,455) |
1,224,347 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-08-24 |
4 |
AS |
$3.71 |
$74,233 |
D/D |
(20,009) |
1,204,338 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-09-23 |
4 |
AS |
$3.07 |
$64,633 |
D/D |
(21,053) |
1,183,285 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-10-25 |
4 |
AS |
$4.40 |
$84,814 |
D/D |
(19,276) |
1,164,009 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-12-23 |
4 |
AS |
$7.10 |
$137,797 |
D/D |
(19,408) |
1,125,228 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-01-24 |
4 |
AS |
$8.56 |
$133,485 |
D/D |
(15,594) |
1,109,634 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-02-22 |
4 |
AS |
$8.43 |
$121,991 |
D/D |
(14,471) |
1,095,163 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-03-23 |
4 |
AS |
$7.30 |
$135,510 |
D/D |
(18,563) |
1,076,600 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-05-23 |
4 |
AS |
$9.58 |
$181,752 |
D/D |
(18,972) |
1,038,253 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-06-22 |
4 |
AS |
$10.01 |
$108,739 |
D/D |
(10,863) |
1,050,405 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-07-24 |
4 |
AS |
$10.99 |
$122,495 |
D/D |
(11,146) |
1,039,259 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-08-22 |
4 |
AS |
$10.83 |
$119,292 |
D/D |
(11,015) |
1,039,644 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-09-22 |
4 |
AS |
$10.19 |
$114,403 |
D/D |
(11,227) |
1,033,721 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-10-24 |
4 |
AS |
$8.99 |
$112,276 |
D/D |
(12,489) |
1,028,751 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-11-22 |
4 |
AS |
$8.68 |
$98,240 |
D/D |
(11,318) |
1,017,433 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-03-30 |
4 |
D |
$4.74 |
$119,704 |
D/D |
(25,254) |
1,412,957 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2022-11-20 |
4 |
D |
$5.00 |
$96,865 |
D/D |
(19,373) |
1,144,636 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-04-20 |
4 |
D |
$8.80 |
$170,500 |
D/D |
(19,375) |
1,057,225 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
CEO |
• • – |
2023-05-31 |
4 |
D |
$9.09 |
$275,118 |
D/D |
(30,266) |
1,061,268 |
0 |
- |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
